INFUSYSTEM HOLDINGS, INC Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent
INFUSYSTEM HOLDINGS, INC (INFU) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent of $41.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, before tax, parent for the quarter ending 2026-06-30 was $41.00K.
- INFUSYSTEM HOLDINGS, INC other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, before tax, parent for the quarter ending 2026-03-31 was $18.00K.
- INFUSYSTEM HOLDINGS, INC other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, before tax, parent for the quarter ending 2025-12-31 was -$102.00K, a 127.20% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, before tax, parent for the quarter ending 2025-09-30 was -$99.00K.
- INFUSYSTEM HOLDINGS, INC other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, before tax, parent for fiscal 2025 was -$733.00K, a 1932.50% decline from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, before tax, parent for fiscal 2024 was $40.00K.
- INFUSYSTEM HOLDINGS, INC other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, before tax, parent for fiscal 2023 was -$523.00K, a 132.50% decline from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC other comprehensive income (loss), cash flow hedge, gain (loss), after reclassification, before tax, parent for fiscal 2022 was $1.61M, a 353.24% increase from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $41.00K 10-Q · filed 2026-08-04 | $59.00K 10-Q · filed 2026-08-04 | -$43.00K derived: sum of 3 quarters · filed 2026-08-04 | -$142.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $18.00K 10-Q · filed 2026-05-08 | -$84.00K derived: sum of 2 quarters · filed 2026-05-08 | -$183.00K derived: sum of 3 quarters · filed 2026-05-08 | -$386.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$201.00K derived: sum of 2 quarters · filed 2026-02-27 | -$404.00K derived: sum of 3 quarters · filed 2026-08-04 | -$733.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | -$99.00K 10-Q · filed 2025-11-04 | -$302.00K derived: sum of 2 quarters · filed 2026-08-04 | -$631.00K 10-Q · filed 2025-11-04 | -$256.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | -$203.00K 10-Q · filed 2026-08-04 | -$532.00K 10-Q · filed 2026-08-04 | -$157.00K derived: sum of 3 quarters · filed 2026-08-04 | -$765.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$329.00K 10-Q · filed 2026-05-08 | $46.00K derived: sum of 2 quarters · filed 2026-05-08 | -$562.00K derived: sum of 3 quarters · filed 2026-05-08 | -$563.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $375.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$233.00K derived: sum of 2 quarters · filed 2026-02-27 | -$234.00K derived: sum of 3 quarters · filed 2026-02-27 | $40.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | -$608.00K 10-Q · filed 2025-11-04 | -$609.00K derived: sum of 2 quarters · filed 2025-11-04 | -$335.00K 10-Q · filed 2025-11-04 | -$1.06M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$1.00K 10-Q · filed 2025-08-05 | $273.00K 10-Q · filed 2025-08-05 | -$450.00K derived: sum of 3 quarters · filed 2025-08-05 | -$196.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $274.00K 10-Q · filed 2025-05-08 | -$449.00K derived: sum of 2 quarters · filed 2025-05-08 | -$195.00K derived: sum of 3 quarters · filed 2025-05-08 | $33.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$723.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$469.00K derived: sum of 2 quarters · filed 2025-03-11 | -$241.00K derived: sum of 3 quarters · filed 2025-03-11 | -$523.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $254.00K 10-Q · filed 2024-11-08 | $482.00K derived: sum of 2 quarters · filed 2024-11-08 | $200.00K 10-Q · filed 2024-11-08 | $55.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $228.00K 10-Q · filed 2024-08-09 | -$54.00K 10-Q · filed 2024-08-09 | -$199.00K derived: sum of 3 quarters · filed 2024-08-09 | $406.00K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | -$282.00K 10-Q · filed 2024-05-09 | -$427.00K derived: sum of 2 quarters · filed 2024-05-09 | $178.00K derived: sum of 3 quarters · filed 2024-05-09 | $422.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $460.00K derived: sum of 2 quarters · filed 2024-04-10 | $704.00K derived: sum of 3 quarters · filed 2024-04-10 | $1.61M 10-K · filed 2024-04-10 |
| 2022-09-30 | $605.00K 10-Q · filed 2023-11-09 | $849.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.75M 10-Q · filed 2023-11-09 | $2.02M derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-06-30 | $244.00K 10-Q · filed 2023-08-09 | $1.15M 10-Q · filed 2023-08-09 | $1.41M derived: sum of 3 quarters · filed 2024-04-10 | $1.45M derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-03-31 | $905.00K 10-Q · filed 2023-05-09 | $1.17M derived: sum of 2 quarters · filed 2024-04-10 | $1.21M derived: sum of 3 quarters · filed 2024-04-10 | $1.10M derived: sum of 4 quarters · filed 2024-04-10 |
| 2021-12-31 | $262.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $303.00K derived: sum of 2 quarters · filed 2024-04-10 | $197.00K derived: sum of 3 quarters · filed 2024-04-10 | $355.00K 10-K · filed 2024-04-10 |
| 2021-09-30 | $41.00K 10-Q · filed 2022-11-08 | -$65.00K derived: sum of 2 quarters · filed 2022-11-08 | $93.00K 10-Q · filed 2022-11-08 | $93.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | -$106.00K 10-Q · filed 2022-08-04 | $52.00K 10-Q · filed 2022-08-04 | $52.00K derived: sum of 3 quarters · filed 2023-03-16 | $52.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $158.00K 10-Q · filed 2022-05-05 | $158.00K derived: sum of 2 quarters · filed 2023-03-16 | $158.00K derived: sum of 3 quarters · filed 2023-03-16 | $158.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $0.00 derived: sum of 3 quarters · filed 2023-03-16 | $0.00 10-K · filed 2023-03-16 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | ||
| 2019-12-31 | $0.00 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |